A recent case published in the journal ACG CASE REPORTS JOURNAL found a possible risk of colonic ischemia caused by the usage ...

Eli Lilly and Company LLY announced that the FDA has approved its popular obesity drug, Zepbound (tirzepatide) for treating ...

Meanwhile, Lilly’s Phase III SUMMIT trial (NCT04847557) found that tirzepatide reduced the risk of heart failure outcomes in patients with heart failure with preserved ejection fraction (HFpEF ...

Each of the four Heart of Neolithic Orkney sites is a masterpiece of Neolithic design and construction in itself. But together they represent one of the richest surviving Neolithic landscapes in ...